Mr. Elam has been founding, managing and advising healthcare and technology companies for more than 30 years.
Prior to founding Rezolute, Mr. Elam held various senior leadership positions in the industry including Senior Vice President at Nektar Therapeutics (NASDAQ: NKTR) where he ran the Pulmonary Business Unit and was instrumental in streamlining the organization and reshaping its pipeline. Prior to negotiating the sale of his division to Novartis, Mr. Elam spun two entities out of Nektar, including Aerogen in Ireland and Pearl Therapeutics, which was acquired by AstraZeneca for $1 billion. Mr. Elam also played a fundamental role in launching Savara, Inc. (NASDAQ: SVRA) where he helped shape the company’s direction and path forward with his rare disease and pulmonary expertise. Mr. Elam also was the Co-Founder and Chief Financial Officer of e2open (NYSE: ETWO), a web-based supply chain platform company serving various industries including healthcare. Early in his career, Mr. Elam was a corporate partner at the law firm of Wilson Sonsini Goodrich & Rosati, where he advised both emerging growth companies and mature corporations such as Genentech and Hewlett Packard, and negotiated several notable deals, including the sale of Steve Jobs’ company, Next, to Apple.
Throughout his career, Mr. Elam has served on the board of directors of various healthcare companies in the US, Europe and Asia. He currently serves on the board of Rezolute and Savara.
Mr. Elam received his B.A. from Howard University and his J.D. from Harvard Law School.
What is Nevan C. Elam's net worth?
The estimated net worth of Nevan C. Elam is at least $2.17 million as of March 27th, 2025. Elam owns 224,119 shares of Rezolute stock worth more than $2,173,954 as of December 4th. This net worth estimate does not reflect any other assets that Elam may own. Additionally, Elam receives a salary of $973,650.00 as CEO at Rezolute. Learn More about Nevan C. Elam's net worth.
How old is Nevan C. Elam?
What is Nevan C. Elam's salary?
How do I contact Nevan C. Elam?
Has Nevan C. Elam been buying or selling shares of Rezolute?
Nevan C. Elam has not been actively trading shares of Rezolute over the course of the past ninety days. Most recently, on Thursday, March 27th, Nevan C. Elam bought 12,302 shares of Rezolute stock. The stock was acquired at an average cost of $2.85 per share, with a total value of $35,060.70. Following the completion of the transaction, the chief executive officer now directly owns 224,119 shares of the company's stock, valued at $638,739.15. Learn More on Nevan C. Elam's trading history.
Who are Rezolute's active insiders?
Are insiders buying or selling shares of Rezolute?
During the last twelve months, Rezolute insiders bought shares 10 times. They purchased a total of 1,299,405 shares worth more than $4,256,190.31. The most recent insider tranaction occured on June, 25th when insider Brian Kenneth Roberts bought 2,500 shares worth more than $10,950.00. Insiders at Rezolute own 14.8% of the company.
Learn More about insider trades at Rezolute. Information on this page was last updated on 6/25/2025.
